LRRK2 is commonly mutated in PD and its increased activity is associated with pathogenesis; LRRK2 AONs have been shown to prevent the formation of α-synuclein inclusions in a PD mouse model [84]. This evidence concerns the gene SNCA and Parkinson disease.